MAKING SCIENCE GROUP SA (ALMKS.PA) Fundamental Analysis & Valuation

EPA:ALMKS • ES0105463006

Current stock price

7.9 EUR
0 (0%)
Last:

This ALMKS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALMKS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMKS has reported negative net income.
  • ALMKS had a positive operating cash flow in the past year.
  • In the past 5 years ALMKS reported 4 times negative net income.
  • ALMKS had a positive operating cash flow in 4 of the past 5 years.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.94%, ALMKS is doing worse than 60.61% of the companies in the same industry.
  • ALMKS's Return On Equity of -4.48% is on the low side compared to the rest of the industry. ALMKS is outperformed by 60.61% of its industry peers.
  • ALMKS has a better Return On Invested Capital (7.00%) than 69.70% of its industry peers.
  • ALMKS had an Average Return On Invested Capital over the past 3 years of 2.93%. This is below the industry average of 7.56%.
  • The 3 year average ROIC (2.93%) for ALMKS is below the current ROIC(7.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROIC 7%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 100 150

1.3 Margins

  • In the last couple of years the Profit Margin of ALMKS has grown nicely.
  • ALMKS has a Operating Margin of 1.87%. This is comparable to the rest of the industry: ALMKS outperforms 43.94% of its industry peers.
  • In the last couple of years the Operating Margin of ALMKS has declined.
  • The Gross Margin of ALMKS (20.58%) is worse than 78.79% of its industry peers.
  • In the last couple of years the Gross Margin of ALMKS has declined.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 20.58%
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALMKS.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALMKS is still creating some value.
  • ALMKS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALMKS has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALMKS has an improved debt to assets ratio.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • ALMKS has an Altman-Z score of 1.79. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.79, ALMKS is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • ALMKS has a debt to FCF ratio of 1.06. This is a very positive value and a sign of high solvency as it would only need 1.06 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.06, ALMKS belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
  • A Debt/Equity ratio of 0.21 indicates that ALMKS is not too dependend on debt financing.
  • ALMKS has a Debt to Equity ratio of 0.21. This is in the better half of the industry: ALMKS outperforms 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Altman-Z 1.79
ROIC/WACC1.03
WACC6.81%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • ALMKS has a Current Ratio of 0.84. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALMKS's Current ratio of 0.84 is on the low side compared to the rest of the industry. ALMKS is outperformed by 60.61% of its industry peers.
  • ALMKS has a Quick Ratio of 0.84. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.82, ALMKS perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.82
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALMKS.PA Growth Analysis

3.1 Past

  • ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.80%, which is quite impressive.
  • The Earnings Per Share has been growing by 64.14% on average over the past years. This is a very strong growth
  • ALMKS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.02%.
  • The Revenue has been growing by 43.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%

3.2 Future

  • The Earnings Per Share is expected to decrease by -63.53% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 16.23% on average over the next years. This is quite good.
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALMKS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALMKS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • ALMKS is valuated quite expensively with a Price/Forward Earnings ratio of 70.41.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALMKS.
  • ALMKS is valuated expensively when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 70.41
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

  • ALMKS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALMKS is cheaper than 60.61% of the companies in the same industry.
  • ALMKS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALMKS is cheaper than 98.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.87
EV/EBITDA 5.78
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as ALMKS's earnings are expected to decrease with -63.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.53%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ALMKS.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.32%, ALMKS has a reasonable but not impressive dividend return.
  • ALMKS's Dividend Yield is comparable with the industry average which is at 3.42.
  • Compared to an average S&P500 Dividend Yield of 1.83, ALMKS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALMKS.PA Yearly Dividends per shareALMKS.PA Yearly Dividends per shareYearly Dividends per share 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y-63.53%
EPS Next 3YN/A
ALMKS.PA Yearly Income VS Free CF VS DividendALMKS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMKS.PA Fundamentals: All Metrics, Ratios and Statistics

MAKING SCIENCE GROUP SA

EPA:ALMKS (4/10/2026, 7:00:00 PM)

7.9

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-19
Earnings (Next)N/A
Inst Owners4.21%
Inst Owner ChangeN/A
Ins Owners58.8%
Ins Owner ChangeN/A
Market Cap71.81M
Revenue(TTM)273.54M
Net Income(TTM)-1.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-70.27%
EPS NY rev (3m)-73.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 70.41
P/S 0.26
P/FCF 1.87
P/OCF 1.86
P/B 1.87
P/tB N/A
EV/EBITDA 5.78
EPS(TTM)-0.19
EYN/A
EPS(NY)0.11
Fwd EY1.42%
FCF(TTM)4.22
FCFY53.44%
OCF(TTM)4.24
OCFY53.68%
SpS30.09
BVpS4.22
TBVpS-2.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROCE 9.53%
ROIC 7%
ROICexc 19.52%
ROICexgc N/A
OM 1.87%
PM (TTM) N/A
GM 20.58%
FCFM 14.03%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ROICexc(3y)5.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.1%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
F-Score6
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Debt/EBITDA 0.63
Cap/Depr 2.28%
Cap/Sales 0.06%
Interest Coverage 1.19
Cash Conversion 304.51%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.82
Altman-Z 1.79
F-Score6
WACC6.81%
ROIC/WACC1.03
Cap/Depr(3y)8.61%
Cap/Depr(5y)162.22%
Cap/Sales(3y)0.2%
Cap/Sales(5y)5.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y279.09%
EBIT growth 3YN/A
EBIT growth 5Y-40.98%
EBIT Next Year83.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76352.4%
FCF growth 3Y58.75%
FCF growth 5YN/A
OCF growth 1Y11729.2%
OCF growth 3Y52.22%
OCF growth 5Y61.77%

MAKING SCIENCE GROUP SA / ALMKS.PA Fundamental Analysis FAQ

What is the fundamental rating for ALMKS stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALMKS.PA.


Can you provide the valuation status for MAKING SCIENCE GROUP SA?

ChartMill assigns a valuation rating of 1 / 10 to MAKING SCIENCE GROUP SA (ALMKS.PA). This can be considered as Overvalued.


How profitable is MAKING SCIENCE GROUP SA (ALMKS.PA) stock?

MAKING SCIENCE GROUP SA (ALMKS.PA) has a profitability rating of 2 / 10.